{"database": "lobbying", "table": "lobbying_activities", "rows": [[1885584, "5b737898-6d5d-4be6-baf5-1092ec5a0cc9", "Q3", "FORBES-TATE", 400976792, "PHRMA", 2016, "third_quarter", "PHA", "Issues related to Medicare Part D; issues related to the drug industry, issues related to comparative effectiveness; issues related to follow-on biologics; issues related to the Independent Payment Advisory Board; issues related to patent reform; issues related to ASP+6 and Part B rule; issues related to PCORI; issues related to pharmaceutical drug safety track and trace program legislation; issues related to low income subsidies; issues related to the Vice President's National Cancer Moonshot Initiative.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2016-10-19T10:57:33.233000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1885584"], "units": {}, "query_ms": 20.766358997207135, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}